Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Paul A. Hoffmeister"'
Autor:
Lei Zhang, Anna Petryk, Julia Steinberger, Donald R. Dengel, Lynda E. Polgreen, Paul A. Hoffmeister, K. S. Baker, James S. Hodges
Publikováno v:
Bone marrow transplantation
Low bone mineral density (BMD) has been reported in recipients of pediatric hematopoietic cell transplantation (HCT), but it is unclear whether age at HCT has a role. The objective of this cross-sectional study was to determine if patients treated wi
Autor:
Mary E.D. Flowers, Rainer Storb, Jean E. Sanders, Ann E. Woolfrey, H. Joachim Deeg, Barry E. Storer, Paul A. Carpenter, Paul A. Hoffmeister
Publikováno v:
Blood. 118:1421-1428
Aplastic anemia (AA), a potentially fatal disease, may be cured with marrow transplantation. Survival in pediatric patients has been excellent early after transplantation, but only limited data are available regarding late effects. This study evaluat
Autor:
Debra L. Friedman, K. Scott Baker, Eric J. Chow, Jill H. Simmons, Christian L. Roth, Paul A. Hoffmeister, Jean E. Sanders
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(12):1674-1681
Survivors of childhood acute lymphoblastic leukemia (ALL) may face an increased risk of metabolic and cardiovascular late effects. To determine the prevalence of and risk factors for adverse cardiometabolic traits in a contemporary cohort of pediatri
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(4):515-524
A retrospective study was conducted to determine risk factors for the development of hypertension (HTN) and to describe the prevalence among long-term survivors of pediatric hematopoietic cell transplant (HCT). Records of 689 pediatric patients who s
Autor:
Paul A. Hoffmeister, Paula M. Charuhas, Barry E. Storer, Ann E. Woolfrey, Jean E. Sanders, Charles H. Chesnut, Paul A. Carpenter
Publikováno v:
Biology of Blood and Marrow Transplantation. 13:683-690
Reduced bone mineral density (BMD) occurs frequently in children after hematopoietic cell transplantation (HCT), but therapy for this complication is undefined. To determine the impact of bisphosphonate therapy on reduced BMD after HCT, we compared b
Publikováno v:
Bone marrow transplantation. 51(1)
Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up
Autor:
Antoinette Moran, K. Scott Baker, Anna Petryk, Aaron S. Kelly, Paul A. Hoffmeister, Eric J. Chow, Julie A. Ross, Lisa S. Chow, Julia Steinberger, Megan E. Slater, Ildiko H. Koves, Jill Lee, Alan R. Sinaiko
Along with other childhood cancer survivors (CCS), hematopoietic cell transplantation (HCT) survivors are at high risk of treatment-related late effects, including cardiovascular disease and diabetes. Cardiometabolic risk factor abnormalities may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba7c5f08c2601ab2a48b9512b5ae8574
https://europepmc.org/articles/PMC4466057/
https://europepmc.org/articles/PMC4466057/
Autor:
Ted Gooley, Robert G. Andrews, Eileen Bryant, Paul A. Carpenter, Frederick R. Appelbaum, Paul A. Hoffmeister, Ho Joon Im, Jean E. Sanders, Ann E. Woolfrey
Publikováno v:
Blood. 105:3749-3756
The role of transplantation in infants with acute lymphoblastic leukemia (ALL) is not defined. We analyzed results of 40 infants diagnosed before age 12 months who received a hematopoietic cell transplant (HCT) between July 1982 and February 2003 in
Publikováno v:
Journal of pediatric hematology/oncology. 36(6)
To determine risk factors for the development of gallstones and the prevalence of related cholecystectomy in children following hematopoietic cell transplantation (HCT).A retrospective chart review of 1343 patients aged below 18 years old who survive
Autor:
Paul A. Hoffmeister, Frederick R. Appelbaum, Laurie A. Milner, Mark C. Walters, Eileen Bryant, Ted Gooley, John A. Hansen, Ann E. Woolfrey, Eric L. Sievers, Jean E. Sanders, Claudio Anasetti, Robert G. Andrews
Publikováno v:
Blood. 92:3546-3556
We analyzed results of 40 infants less than 2 years of age who received bone marrow transplants (BMT) between May 1974 and January 1995 for treatment of acute myelogenous leukemia (AML; N = 34) or myelodysplastic syndrome (MDS; N = 6) to determine ou